Literature DB >> 23602756

Ulinastatin improved cardiac dysfunction after cardiac arrest in New Zealand rabbits.

Chun Lin Hu1, Hui Li, Jin Ming Xia, Xin Li, Xiaoyun Zeng, Xiao Xing Liao, Hong Zhan, Xiao Li Jing, Gang Dai.   

Abstract

OBJECTIVE: The present study was designed to evaluate the effects of ulinastatin (UTI) on cardiac dysfunction after cardiopulmonary resuscitation (CPR).
METHODS: A total of 48 healthy adult male New Zealand rabbits were untreated for 8 minutes after the induction of ventricular fibrillation (VF) by an external transthoracic alternating current and then treated by CPR. These rabbits were then randomly divided into the control and UTI groups after the return of spontaneous circulation (ROSC) and were observed for 8 hours after the ROSC. Before CPR and after ROSC at 2, 4, and 8 hours, blood samples were collected to determine the levels of tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), malondialdehyde (MDA), cardiac troponin I (cTnI), and N-terminal probrain natriuretic peptide (NT-proBNP), and the left ventricular ejection fraction (EF) was measured by echocardiography.
RESULTS: Nineteen of 24 rabbits in the control group and 18 of 24 in the UTI group were successfully resuscitated. The plasma levels of TNF-α, IL-6, MDA, cTnI, and NT-proBNP were significantly increased, accompanying a deceased EF in the control group, but the cotreatment with UTI decreased the plasma levels of TNF-α, IL-6, MDA, cTnI, and NT-proBNP (P < .05), attenuating the myocardial injury and improving the EF in the UTI group. Only 9 of 19 animals in the control group but 14 of 18 animals in the UTI group survived longer than 8 hours (P = .011).
CONCLUSIONS: The progression of proinflammatory responses, oxidative stress, and myocardial injury have been linked to the reduced EF after VF/CPR, and the administration of UTI at a cardioprotective dosage preserved the cardiac function after VF/CPR.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23602756     DOI: 10.1016/j.ajem.2012.11.012

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

1.  Pre-arrest hypothermia improved cardiac function of rats by ameliorating the myocardial mitochondrial injury after cardiac arrest.

Authors:  Yuanzheng Lu; Xiaoyun Zeng; Xiaoli Jing; Meixian Yin; Mms Mary P Chang; Hongyan Wei; Yan Yang; Xiaoxing Liao; Gang Dai; Chunlin Hu
Journal:  Exp Biol Med (Maywood)       Date:  2019-09-17

2.  The regulation effect of ulinastatin on the expression of SSAT2 and AQP4 in myocardial tissue of rats after cardiopulmonary resuscitation.

Authors:  Wujian He; Yufang Liu; Hongxia Geng; Yanzhen Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Ulinastatin Protects against CVB3-Induced Acute Viral Myocarditis through Nrf2 Activation.

Authors:  Fangqiang Song; Fanpo Kong; Hongqing Zhang; Yongqin Zhou; Ming Li
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

4.  Effect of urinary protease inhibitor (ulinastatin) on cardiopulmonary bypass: a meta-analysis for China and Japan.

Authors:  Yun Zhang; Zhi Zeng; Yu Cao; Xiaodong Du; Zhi Wan
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

5.  Ulinastatin protects against sepsis‑induced myocardial injury by inhibiting NLRP3 inflammasome activation.

Authors:  Juanjuan Qiu; Xiaoguang Xiao; Xue Gao; Yongli Zhang
Journal:  Mol Med Rep       Date:  2021-08-20       Impact factor: 2.952

6.  Ulinastatin attenuates diabetes-induced cardiac dysfunction by the inhibition of inflammation and apoptosis.

Authors:  Wen-Ke Wang; Qing-Hua Lu; Xin Wang; Ben Wang; Juan Wang; Hui-Ping Gong; Lin Wang; Hao Li; Yi-Meng Du
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.